NASDAQ
Aptevo Therapeutics Inc. (APVO) has a revenue compound annual growth rate of -26.64% over 5 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.